Literature DB >> 1249818

Inhibition of tumor cell transplantability by iron and copper complexes of 5-substituted 2-formylpyridine thiosemicarbazones.

W E Antholine, J M Knight, D H Petering.   

Abstract

The cytotoxicity of copper and iron complexes of 5-substituted 2-formylpyridine thiosemicarbazones against Ehrlich ascites tumor cells has been measured. Brief in vitro incubation of cells and drugs is followed by implantation into host mice. Subsequent degree of tumor development is a measure of cytotoxicity. A spectrum of activities for the iron complexes is observed, starting with the least active as designated by its 5-substitution: OH less than OCOCH3 approximately N(CH3)2 less than H less than CH3 approximately Cl approximately CF3. The last three complexes can prevent completely tumor growth in the new host. Copper complexes of 5-H and 5-CH3 also prevent successful tumor cell transplantation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1249818     DOI: 10.1021/jm00224a030

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo.

Authors:  Chad N Hancock; Luke H Stockwin; Bingnan Han; Raymond D Divelbiss; Jung Ho Jun; Sanjay V Malhotra; Melinda G Hollingshead; Dianne L Newton
Journal:  Free Radic Biol Med       Date:  2010-11-04       Impact factor: 7.376

2.  Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs.

Authors:  Daniel Sun; Juno Van Valkenburgh; Sheba Plamthottam; Jeffrey Valenzuela; Bastian Ruehle; Dalton Steele; Soumya Poddar; Maxim Marshalik; Selena Hernandez; Caius Gabriel Radu; Jeffrey I Zink
Journal:  J Biol Inorg Chem       Date:  2019-06-27       Impact factor: 3.358

3.  Complexes of 3d(n) metal ions with thiosemicarbazones: synthesis and antimicrobial activity.

Authors:  Tudor Rosu; Aurelian Gulea; Anca Nicolae; Rodica Georgescu
Journal:  Molecules       Date:  2007-04-17       Impact factor: 4.411

4.  Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.

Authors:  Jill M Kolesar; William R Schelman; Peter G Geiger; Kyle D Holen; Anne M Traynor; Dona B Alberti; James P Thomas; Christopher R Chitambar; George Wilding; William E Antholine
Journal:  J Inorg Biochem       Date:  2007-10-30       Impact factor: 4.155

5.  Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity.

Authors:  Henning Karlsson; Mårten Fryknäs; Sara Strese; Joachim Gullbo; Gunnar Westman; Ulf Bremberg; Tobias Sjöblom; Tatjana Pandzic; Rolf Larsson; Peter Nygren
Journal:  Oncotarget       Date:  2017-05-02

6.  Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance Circumvention.

Authors:  Christian R Kowol; Walter Miklos; Sarah Pfaff; Sonja Hager; Sebastian Kallus; Karla Pelivan; Mario Kubanik; Éva A Enyedy; Walter Berger; Petra Heffeter; Bernhard K Keppler
Journal:  J Med Chem       Date:  2016-07-07       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.